The overall goal of this study is to explore the effectiveness of using acupuncture versus aromatherapy, in conjunction with standard of care anti-emetics, to decrease chemotherapy induced nausea, vomiting, and anxiety in breast cancer patients undergoing Adriamycin and Cytoxan. This study also aims to determine if aromatherapy and anti-emetics is more effective than acupuncture and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan and if acupuncture and anti-emetics is more effective than aromatherapy and anti-emetics in treating nausea, vomiting, and anxiety in patients receiving Adriamycin and Cytoxan.

i) Inclusion

• At least 18 years of age on the day of signing informed consent
• Patient has a diagnosis of breast cancer
• Patient is planned to start Adriamycin and Cytoxan chemotherapy

ii) Exclusion

• Patients who are unable to adhere to the protocol or treatment schedule
• Patients who have a concurrent illness or take medication that induces nausea independent of chemotherapy
• Patients undergoing radiotherapy or hormone therapy during chemotherapy treatments
• Patients who have a sensitive and/or poor sense of smell
• Patients who are allergic to essential oils, specifically peppermint, ginger, and/or lavender
• Patients who are already using essential oils or acupuncture for symptom management and are unwilling to stop while participating in this study
• Patients who are afraid of or unwilling to receive acupuncture stimulation
• Patients who are allergic to stainless steel needles
• Thrombocytopenia (Platelets < 20,000)
• Patients who have received aromatherapy and/or acupuncture treatment within 1 week of starting treatment on this study